Washington, DC: Mylan Pharmaceuticals and chemical companies Cambrex and Gyma Laboratories have been ordered to pay $67 million in fines to end the long-running antitrust lawsuit brought by Blue Cross. [Original Article]
Washington, DC: Mylan Pharmaceuticals and chemical companies Cambrex and Gyma Laboratories have been ordered to pay $67 million in fines to end the long-running antitrust lawsuit brought by Blue Cross. [Original Article]